Polaris Group (TPE:6550)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.75
-0.15 (-0.42%)
Oct 7, 2025, 11:44 AM CST
-0.42%
Market Cap27.66B
Revenue (ttm)64.02M
Net Income (ttm)-3.07B
Shares Out770.43M
EPS (ttm)-4.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume452,852
Average Volume493,669
Open36.05
Previous Close35.90
Day's Range35.50 - 36.45
52-Week Range26.35 - 55.20
Beta0.13
RSI37.38
Earnings DateNov 11, 2025

About Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications. It also provides healthcare consulting, staffing, and MDS solutions. The company was founded in 1988 and is based in Tampa, Florida. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 165
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6550
Full Company Profile

Financial Performance

In 2024, Polaris Group's revenue was 107.00 million, an increase of 1330.29% compared to the previous year's 7.48 million. Losses were -2.50 billion, 67.7% more than in 2023.

Financial Statements

News

There is no news available yet.